H.R.es172 - Raising awareness for the sarcoma cancer chordoma. (119th Congress)
Summary
H.Res.172 is a resolution introduced in the House of Representatives to raise awareness for chordoma, a rare bone cancer. The resolution expresses the sense of the House that increased funding and support are needed for accurate diagnosis, new treatments, and patient-centric approaches to drug discovery. It highlights the challenges in treating chordoma and the lack of effective treatments for advanced cases.
The resolution does not create any new laws or allocate specific funding. It serves as a statement of support and a call for action to address the needs of chordoma patients and their families.
The bill was submitted to the Committee on Energy and Commerce.
Expected Effects
If passed, this resolution would likely increase public awareness of chordoma. This could lead to increased research funding and support for patients and families affected by the disease. However, the resolution itself does not guarantee any concrete changes in funding or treatment options.
It may also encourage pharmaceutical companies and research institutions to prioritize the development of new treatments and diagnostics for chordoma. The resolution's emphasis on patient-centric approaches could influence the design of clinical trials and the delivery of care.
Ultimately, the impact of the resolution will depend on whether it translates into tangible actions, such as increased funding allocations and policy changes.
Potential Benefits
- Increased awareness of chordoma among the public and medical community.
- Potential for increased research funding for diagnosis, treatment, and cures.
- Encouragement of patient-centric approaches to drug discovery and development.
- Faster translation of research findings into new treatments.
- Improved support for chordoma patients and their families.
Most Benefited Areas:
Potential Disadvantages
- The resolution itself does not guarantee any actual funding or policy changes.
- Increased awareness may not necessarily translate into concrete improvements in treatment options.
- The focus on one specific rare disease may divert resources from other important areas of medical research.
- There are no immediate or direct disadvantages, but the lack of concrete action could lead to disappointment if expectations are not managed.
- The resolution could be seen as symbolic without real impact.
Constitutional Alignment
This resolution appears to align with the general welfare clause of the Constitution, as it aims to promote public health by raising awareness and encouraging research for a rare cancer. The Constitution's preamble states the goal to "promote the general Welfare".
However, the resolution itself does not enact any laws or allocate funding, so it does not directly implicate any specific constitutional provisions regarding legislative power or appropriations (Article I, Section 8).
Furthermore, the resolution does not infringe upon any individual rights or liberties protected by the Bill of Rights.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).